Cardiovascular disease (CVD) is the world’s leading cause of morbidity and mortality as well as the health industry’s most costly disease for treatment. Yet, despite recent advances in its treatment, more effective and accessible ways to tackle CVDs remain to be discovered.
Hong Kong Centre for Cerebro-cardiovascular Health Engineering (COCHE) is taking on the challenge to develop new ways to treat CVD with innovative technologies allowing early prediction and intervention, so people can stay a step ahead of the disease. These technologies can also reduce the human cost, as well as alleviate both the financial and social burden, on the healthcare system.
COCHE is focusing on the development of groundbreaking systems to enable early diagnosis and intervention using cerebro-cardiovascular health engineering, in particular:
Wearable Technologies, including flexible sensing and soft robotics that can be worn either externally or inside the body. Sensors re being designed to help users stay healthy and in shape, monitor CVD risk factors, detect life-threatening conditions and provide on-site, real-time CVD therapies.
Micro-nano-biosensors, which are developed and adapted to provide ultra-sensitive detection of biomarkers that would send an alert that an individual is developing the disease.
Multi-modal and multi-scale medical imaging technologies that can be used to develop tools for precise evaluation of the vulnerability of blood plaque.
Artificial intelligence (AI) integrating and analysing information obtained by wearable devices, biosensors and medical imaging technologies for early identification and prediction of vulnerable CVD patients.
A team of world-class multi-disciplinary experts in wearable technologies, bio-sensing, medical imaging and artificial intelligence
Established under
In collaboration with
